WCG Clinical, Inc. - FORM S-1/A - EX-23.1 - July 27, 2021

Attached files

file filename
EX-99.1 - EX-99.1 - WCG Clinical, Inc.d108549dex991.htm
EX-23.2 - EX-23.2 - WCG Clinical, Inc.d108549dex232.htm
EX-21.1 - EX-21.1 - WCG Clinical, Inc.d108549dex211.htm
EX-10.13 - EX-10.13 - WCG Clinical, Inc.d108549dex1013.htm
EX-10.12 - EX-10.12 - WCG Clinical, Inc.d108549dex1012.htm
EX-10.11 - EX-10.11 - WCG Clinical, Inc.d108549dex1011.htm
EX-10.8 - EX-10.8 - WCG Clinical, Inc.d108549dex108.htm
EX-10.7 - EX-10.7 - WCG Clinical, Inc.d108549dex107.htm
EX-10.6 - EX-10.6 - WCG Clinical, Inc.d108549dex106.htm
EX-10.4 - EX-10.4 - WCG Clinical, Inc.d108549dex104.htm
EX-10.3 - EX-10.3 - WCG Clinical, Inc.d108549dex103.htm
EX-5.1 - EX-5.1 - WCG Clinical, Inc.d108549dex51.htm
EX-4.3 - EX-4.3 - WCG Clinical, Inc.d108549dex43.htm
EX-4.2 - EX-4.2 - WCG Clinical, Inc.d108549dex42.htm
EX-4.1 - EX-4.1 - WCG Clinical, Inc.d108549dex41.htm
EX-3.4 - EX-3.4 - WCG Clinical, Inc.d108549dex34.htm
EX-3.2 - EX-3.2 - WCG Clinical, Inc.d108549dex32.htm
EX-3.1 - EX-3.1 - WCG Clinical, Inc.d108549dex31.htm
EX-1.1 - EX-1.1 - WCG Clinical, Inc.d108549dex11.htm
S-1/A - AMENDMENT NO. 1 TO FORM S-1 - WCG Clinical, Inc.d108549ds1a.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the use in this Registration Statement No. 333-257611 on Form S-1 of our report dated May 11, 2021 (June 17, 2021 as it relates to Note 9 to the financial statements and, July 27, 2021 as to the effects of the stock split discussed in Note 9 to the financial statements), relating to the financial statements of WCG Clinical, Inc. and subsidiaries. We also consent to the reference to us under the heading “Experts” in such Registration Statement.

/s/ Deloitte & Touche LLP

Parsippany, New Jersey

July 27, 2021